1. Academic Validation
  2. N-tert-butyl-N'-(2-cyclohexylamino-5-nitrobenzenesulfonyl)urea, BM531, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition

N-tert-butyl-N'-(2-cyclohexylamino-5-nitrobenzenesulfonyl)urea, BM531, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition

  • Acta Crystallogr C. 2002 Oct;58(Pt 10):o621-3. doi: 10.1107/s0108270102016463.
Catherine Michaux 1 Jean-Michel Dogné Bernadette Norberg François Durant Bernard Masereel
Affiliations

Affiliation

  • 1 Laboratoire de Chimie Moléculaire Structurale, Facultés Universitaires N-D de la Paix, 61 Rue de Bruxelles, B-5000 Namur, Belgium. catherine.michaux@fundp.ac.be
Abstract

The title compound (BM531), C(17)H(26)N(4)O(5)S, has been designed for use as both a thromboxane synthase inhibitor (TXSI) and a thromboxane receptor antagonist (TXRA). We report here the X-ray crystal structure determination of the compound.

Figures
Products